The Company maintained its revenue guidance of $8-10 million for the fiscal year ending March 31, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XAIR:
- XAIR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Beyond Air Stockholders Approve Directors and Equity Plan
- Beyond Air files to sell 7.86M shares of common stock for holders
- XTL Biopharmaceuticals provides update on recent developments
- Beyond Air Announces $5 Million Private Placement Financing
